SC 13G Filing

Company

Keros Therapeutics, Inc.

Filed

December 30, 2021

Accession Number

0001172661-21-002445

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →